|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
1 Broadway,Cambridge,Massachusetts,US
|
|
Advancing research, development and therapy for ALS and additional CNS indications.
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.
Currently in preparations towards a Phase IIb in ALS patients in USA and Israel.
|
NeuroSense Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used NeuroSense Therapeutics email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact NeuroSense Therapeutics customer service number call here +972-9-9531142. To contact NeuroSense Therapeutics customer service number in your country click here to find.
Alon Ben-noon is the CEO of NeuroSense Therapeutics. To contact Alon Ben-noon email at [email protected] or [email protected]. Or you may call +972523757325
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.